市场调查报告书
商品编码
1368745
胃肠支架市场 - 按产品、按应用、材料、最终用途和预测,2023 年至 2032 年Gastrointestinal Stents Market - By Product, By Application, By Material, By End-use, & Forecast, 2023 - 2032 |
2023 年至 2032 年间,全球胃肠支架市场的复合年增长率将达到 5.2%。领先公司之间的合作和收购数量不断增加,支持了市场成长。例如,2023年2月,奥林巴斯出价3.7亿美元收购Taewoong Medical,这是一家专门生产胃肠道手术内视镜设备的韩国公司。奥林巴斯在其公告中强调了 Taewoong 的各种金属胃肠支架。这些支架在旨在缓解癌症或其他消化系统疾病等疾病引起的胆道、食道、结肠或十二指肠阻塞或狭窄的微创手术中发挥关键作用。
这些合作增强了研发能力,促进创新并扩大市场范围。随着公司联合起来,他们利用综合专业知识来开发先进的支架技术,从而增加需求并改善患者护理。这一趋势正在重塑产业格局,推动胃肠支架市场成长。
整个胃肠支架市场根据产品、应用和地区进行分类。
食道支架细分市场从 2023 年到 2032 年将经历重大发展。食道支架对于食道癌和食道狭窄等各种疾病的治疗至关重要。它们的微创性质以及缓解吞嚥困难和预防併发症的有效性使其成为重要的医疗解决方案。胃肠道支架市场需求的不断增长证明了它们对于改善食道问题患者的生活品质具有重要意义。
从 2023 年到 2032 年,大肠直肠癌细分市场将出现显着的复合年增长率。结直肠支架提供了一种微创方法,可以缓解肿瘤引起的阻塞,促进排便并减轻疼痛。它们在安宁疗护和作为手术桥樑方面的有效性导致了越来越多的采用。这表明结直肠支架在改善此类癌症患者的生活品质方面发挥关键作用,进一步巩固了其在胃肠道支架市场成长中的作用。
欧洲胃肠道支架市场从2023年到2032年将呈现可观的复合年增长率。人口老化和胃肠道疾病流行等因素推动了这一增长。例如,根据欧洲联合胃肠病学 (UEG) 报告,欧洲地区估计有超过 3.32 亿消化系统疾病患者。此外,支架技术和微创手术的进步正在推动更高的采用率。欧洲对胃肠道支架的需求凸显了它们在改善患者治疗效果方面的作用以及该地区对医疗保健创新的承诺。
Global Gastrointestinal Stents Market will witness 5.2% CAGR between 2023 and 2032. The rising number of partnerships and acquisitions between leading companies supports market growth. For instance, in February 2023, Olympus put forth a bid of $370 million to acquire Taewoong Medical, a South Korean company specializing in the production of endoscopic devices for gastrointestinal procedures. Olympus highlighted Taewoong's extensive range of metallic gastrointestinal stents in their announcement. These stents play a pivotal role in minimally invasive procedures aimed at alleviating blockages or narrowing in the biliary tract, esophagus, colon, or duodenum caused by conditions such as cancer or other digestive system ailments.
These collaborations enhance research and development capabilities, foster innovation, and expand market reach. As companies join forces, they leverage combined expertise to develop advanced stent technologies, leading to increased demand and improved patient care. This trend is reshaping the industry landscape, driving progress in gastrointestinal stents market growth.
The overall Gastrointestinal Stents Market is classified based on product, application, and region.
Esophageal stents segment will undergo significant development from 2023 to 2032. Esophageal stents are crucial in the management of various conditions, such as esophageal cancer and strictures. Their minimally invasive nature and effectiveness in relieving dysphagia and preventing complications make them a vital medical solution. This growing gastrointestinal stents market demand supports their significance in improving the quality of life for patients with esophageal issues.
Colorectal cancer segment will register a noteworthy CAGR from 2023 to 2032. Colorectal stents offer a minimally invasive approach to relieve obstructions caused by tumors, facilitating bowel movements and reducing pain. Their effectiveness in palliative care and as a bridge to surgery has led to increased adoption. This demonstrates the pivotal role of colorectal stents in improving the quality of life for patients battling this type of cancer, further solidifying its role in the gastrointestinal stents market growth.
Europe gastrointestinal stents market will showcase an appreciable CAGR from 2023 to 2032. Factors like the aging population and the prevalence of gastrointestinal diseases are contributing to this growth. For instance, according to the United European Gastroenterology (UEG) reports, the European region is home to an estimated population of more than 332 million individuals with digestive disorders. Moreover, advancements in stent technology and minimally invasive procedures are driving higher adoption rates. The demand for gastrointestinal stents in Europe underscores their role in enhancing patient outcomes and the region's commitment to healthcare innovation.